Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels
Author:
Affiliation:
1. Centro Universitario de Investigaciones Biomédicas , Universidad de Colima , Colima , COL 28045, México
2. Departamento de Fisiología y Biofísica, Facultad de Medicina , Universidad Autónoma de San Luis Potosí , San Luis Potosí, SLP 78210, México
Abstract
Publisher
Walter de Gruyter GmbH
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Link
https://www.sciendo.com/pdf/10.2478/acph-2021-0017
Reference25 articles.
1. 1. D. McTavish, K. L. Goa and M. Ferrill, Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy, Drugs39 (1990) 552–574; https://doi.org/10.2165/00003495-199039040-0000610.2165/00003495-199039040-00006
2. 2. F. Register, Proposal to withdraw approval of two new drug applications and one abbreviated new drug application; opportunity for a hearing. Food and Drug Administration [Docket No. 96N-0512], Federal Register62 (1997) 2–9.
3. 3. T. J. MacConnell and A. J. Stanners, Torsades de pointes complicating treatment with terfenadine, BMJ302 (1991) 1469; https://doi.org/10.1136/bmj.302.6790.1469-b10.1136/bmj.302.6790.1469-b
4. 4. K. Kamiya, R. Niwa, M. Morishima, H. Honjo and M. C. Sanguinetti, Molecular determinants of hERG channel block by terfenadine and cisapride, J. Pharmacol. Sci. 108 (2008) 301–307; https://doi.org/10.1254/jphs.08102fp10.1254/jphs.08102FP
5. 5. H. R. Lu, A. N. Hermans and D. J. Gallacher, Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?, Br. J. Pharmacol. 166 (2012) 1490–1502; https://doi.org/10.1111/j.1476-5381.2012.01880.x10.1111/j.1476-5381.2012.01880.x
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Terfenadine, a histamine H1 receptor antagonist, induces apoptosis by suppressing STAT3 signaling in human colorectal cancer HCT116 cells;Frontiers in Pharmacology;2024-06-13
2. Therapeutic Targeting of Potassium Channels;Ion Channels as Targets in Drug Discovery;2024
3. Multitargeting in cardioprotection: An example of biaromatic compounds;Archiv der Pharmazie;2023-06-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3